$CBLL

BURKE WILLIAM W sold $44K of CBLL

BURKE WILLIAM W sold 2,207 shares of Ceribell, Inc. (CBLL) at $19.84 on 2026-06-30 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · BURKE WILLIAM W
Published Jul 2, 2026, 4:08 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 4:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CBLL
Neutral
medium confidence
Mentioned
$CBLL
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBLLNeutralLow
01

Why it matters

A director’s pre-arranged open-market sale is generally not a fundamental catalyst; it may marginally influence sentiment but rarely drives price by itself.

02

Market read

Traders may note the insider sale for sentiment monitoring, but there is no new guidance, trial, deal, or regulatory development.

03

What to watch

The disclosure does not indicate whether the director sold for diversification/taxes versus any negative view; also, 10b5-1 timing reduces interpretability.

Relevance 2/10Novelty 3/10Timing: SEC Form 4 filed 2026-07-02 (sale dated 2026-06-30)

Background

The article is an SEC Form 4 insider transaction disclosure for Ceribell, Inc. (CBLL).

Company-level read

Ticker impact

$CBLLNeutralMedium confidence
Context

Form 4 shows director BURKE WILLIAM W sold 2,207 shares of Ceribell at $19.84 on 2026-06-30 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this disclosure.

Evidence & confidence

The filing is a pre-arranged 10b5-1 open-market sale by a director; size ($43.8k) is modest and not accompanied by new operational/regulatory/financial facts.

Market effects

No sector-level read-through; this is an individual insider transaction without new company fundamentals.

None.

None.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with internal caution; traders may watch for follow-on sales or changes in buying behavior.

Key entities

  • Ceribell, Inc.

    CBLL; subject of the Form 4 insider sale disclosure.

  • BURKE WILLIAM W

    Director who sold 2,207 shares on 2026-06-30 under a 10b5-1 plan.

Related articles